196,40 €
0,03 % vorgestern
L&S, 24. Oktober, 22:55 Uhr
ISIN
US00287Y1091
Symbol
ABBV
Berichte

AbbVie Aktie News

Neutral
Seeking Alpha
etwa 5 Stunden alt
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Positiv
The Motley Fool
3 Tage alt
Added 304,281 shares in AbbVie; estimated transaction value of $61.96 million Trade value was 0.23% of the fund's reportable U.S. equity assets under management Post-trade stake: 2,324,286 shares valued at $538.17 million as of September 30, 2025 The position now accounts for 2.01% of 13F assets, placing it outside the fund's top five holdings
Positiv
The Motley Fool
4 Tage alt
Explore the exciting world of AbbVie (ABBV 1.17%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
Neutral
PRNewsWire
5 Tage alt
Each winner will be awarded a $20,000 grant to fuel their businesses. Since the program's inception, BOTOX® Cosmetic has awarded more than $1 million in grants to The Confidence Project entrepreneurs.
Positiv
Reuters
6 Tage alt
AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira, meeting the main goal of a head-to-head trial.
Neutral
PRNewsWire
6 Tage alt
Upadacitinib demonstrated superiority versus adalimumab for  primary endpoint of achieving low disease activity (DAS28-CRP≤3.2) and ranked secondary endpoint of remission (DAS28-CRP
Positiv
Seeking Alpha
9 Tage alt
AbbVie earns a Strong Buy rating in my book, driven by Rinvoq's label expansions and robust immunology pipeline growth. ABBV achieved FDA approval for Rinvoq in giant cell arteritis and reported strong phase 3 results for severe alopecia areata, supporting long-term revenue growth. The acquisition of Capstan Therapeutics brings CPTX2309, a first-in-class tLNP CAR-T candidate, potentially transf...
Neutral
PRNewsWire
9 Tage alt
Acquisition expands AbbVie's psychiatry pipeline with the addition of a next-generation psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD). NORTH CHICAGO, Ill.
Mehr News anzeigen

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen